EEG AND AUDITORY EVOKED-POTENTIAL P300 COMPARED WITH PSYCHOMETRIC TESTS IN ASSESSING VIGILANCE AFTER BENZODIAZEPINE SEDATION AND ANTAGONISM

被引:35
作者
ENGELHARDT, W [1 ]
FRIESS, K [1 ]
HARTUNG, E [1 ]
SOLD, M [1 ]
DIERKS, T [1 ]
机构
[1] UNIV WURZBURG,PSYCHIAT CLIN,DEPT NEUROPHYSIOL,W-8700 WURZBURG,GERMANY
关键词
ANTAGONISTS; BENZODIAZEPINE; FLUMAZENIL; BRAIN; AUDITORY EVOKED RESPONSES; HYPNOTICS; MIDAZOLAM; PSYCHOLOGICAL RESPONSES; VIGILANCE;
D O I
10.1093/bja/69.1.75
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We have compared the EEG and auditory evoked wave P300 with psychometric tests in assessing vigilance after flumazenil antagonism of midazolam sedation in 12 healthy volunteers. Measurements were made before and after midazolam 0.1 and 0.2 mg kg-1 i.v., and immediately and 30, 60, 120 and 240 min after administration of flumazenil 1 mg. The sedative effects of midazolam and antagonism by flumazenil resulted in alterations in EEG, P300 and psychometric tests (syndrome short test, letter cancellation, choice reaction and recognition). However, 60 and 120 min after flumazenil a decrease in test performance indicating rebound sedation was seen only in P300 mapping. Thus P300 mapping was a sensitive method of detecting subtle differences in vigilance. Rebound sedation occurred even when midazolam 0.2 mg kg-1 was antagonized with an adequate dose of flumazenil. We suggest that it is advisable to supervise patients for at least 240 min after flumazenil antagonism of midazolam 0.2 mg kg-1.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 33 条
  • [1] MIDAZOLAM KINETICS
    ALLONEN, H
    ZIEGLER, G
    KLOTZ, U
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) : 653 - 661
  • [2] DOUBLE-BLIND-STUDY OF THE REVERSAL OF MIDAZOLAM-SUPPLEMENTED GENERAL-ANESTHESIA WITH RO-15-1788
    ALON, E
    BAITELLA, L
    HOSSLI, G
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1987, 59 (04) : 455 - 458
  • [3] AMREIN R, 1988, EUR J ANAESTHESIO S2, V5, P65
  • [4] BARTELSMAN J F W M, 1990, Gastrointestinal Endoscopy, V36, pS9
  • [5] BIRCH B, 1990, Journal of Psychopharmacology, V4, P29, DOI 10.1177/026988119000400105
  • [6] BRICKENKAMP R, 1978, AUFMERKSAMKEITSBELAS
  • [7] DIERKS T, 1990, MARKERS PARKINSONS A, P197
  • [8] DUNK AA, 1990, ALIMENT PHARM THERAP, V4, P35
  • [9] ERZIGKEIT H, 1986, MANUAL SKT FORMEN A
  • [10] FRAGEN RJ, 1990, ANESTHESIA ANALGESIA, V70, pS113